Median Technologies SA (ALMDT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Median Technologies SA (ALMDT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010887
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company provides services such as imaging services for CT, companion and monitoring tests; managed services and investigator site network services. Median’s imaging services comprise regulations compliance, project management, data management and quality control; biostatistics and data analysis; and IT services. It provides iBiopsy, a phenomics platform designed to acquire, index, and analyze individual phenotypes and establish biological associations with high predictive accuracy. The company markets its solutions to pharmaceutical companies, institutions, hospitals, and cancer clinics. Median is headquartered in Nice, France.

Median Technologies SA (ALMDT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Median Technologies SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Median Technologies SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Median Technologies SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Median Technologies SA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Median Technologies SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Median Technologies SA, Medical Equipment, Deal Details 11
Venture Financing 11
MEDIAN Technologies Secures USD0.67 Million in Venture Funding 11
Partnerships 12
Median Technologies Enters into Research Agreement with Xingtai People’s Hospital 12
Median Technologies Partners with Microsoft 13
Median Technologies Partners with START 14
MEDIAN Technologies Enters Into Co-Development Agreement With Canon 15
Equity Offering 16
Median Technologies Raises USD21.8 Million in Private Placement of Shares 16
Median Technologies Raises USD22 Million in Private Placement of Shares 17
Median Technologies Raises USD26.5 Million in Private Placement of Units 19
MEDIAN Technologies Completes IPO Of US$14 Million 21
Median Technologies SA – Key Competitors 22
Median Technologies SA – Key Employees 23
Median Technologies SA – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Oct 10, 2017: Median Technologies: H1 2017 results: half-year marked by major investments to structure the company and prepare for the future 25
Apr 12, 2017: Median Technologies Reports Full Year 2016 Financial Results 27
Apr 12, 2016: MEDIAN Technologies: 2015 Results 29
Corporate Communications 30
Nov 09, 2017: Median Technologies Appoints Dr. Peter Bannister as Chief Technology Officer 30
Oct 26, 2017: Median Technologies strengthens its medical leadership with the appointment of Dr. Loan Hoang-Sayag as Chief Medical Officer and the appointment of Dr. Fabien Ricard as Medical Director, North America 31
Oct 19, 2017: Median Technologies Appoints Vivian Wang as General Manager, China and Takashi Hayashi as Managing Director, Japan 32
Nov 15, 2016: MEDIAN Technologies announces management changes 33
Nov 15, 2016: MEDIAN Technologies appoints new COO and chief commercial officer 34
Jul 12, 2016: MEDIAN Technologies strengthens its medical expertise department by appointing Dr. Nathalie Faye as Medical Director Europe 35
Product News 36
Dec 14, 2017: Median Technologies Launches iSee- a Comprehensive Technology Platform to Enhance Medical Imaging Analysis in Clinical Trials 36
Nov 14, 2017: Median Technologies to Present at Medidata NEXT Global 2017 to Discuss How New Technologies Can Optimize Image Management in Clinical Trial 37
Nov 07, 2017: Median Technologies to Present at Medidata NEXT Global 2017 to Discuss How New Technologies Can Optimize Image Management in Clinical Trials 38
Oct 17, 2017: Median Technologies to Attend The Liver Meeting of The American Association for the Study of Liver Diseases to Be Held October 20-24, 2017 in Washington, DC, USA 39
Sep 06, 2017: Median Technologies to Attend the ESMO 2017 Congress, September 8-12, 2017, Madrid, Spain 40
May 31, 2017: Median Technologies to attend the 2017 ASCO Annual Meeting, June 2-6, 2017, McCormick Place, Chicago, IL, USA 41
Apr 13, 2016: MEDIAN Technologies to Present Results of a Study at the Annual Meeting of the American Association for Cancer Research in New Orleans 42
Other Significant Developments 43
Nov 28, 2017: Median Technologies inks a collaboration agreement with Memorial Sloan Kettering Cancer Center for a study dealing with prostate cancer 43
Oct 31, 2017: Median Technologies adds MediScan to its product portfolio 44
Jun 28, 2016: MEDIAN Technologies and START expand relationship to three new centers in Grand Rapids, MI and Madrid, Spain 45
May 03, 2016: MEDIAN Technologies: Order Intake Totaling €3.32M for Q1, 2016 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Median Technologies SA, Medical Equipment, Key Facts, 2016 2
Median Technologies SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Median Technologies SA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Median Technologies SA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Median Technologies SA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Median Technologies SA, Deals By Market, 2011 to YTD 2017 9
Median Technologies SA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
MEDIAN Technologies Secures USD0.67 Million in Venture Funding 11
Median Technologies Enters into Research Agreement with Xingtai People’s Hospital 12
Median Technologies Partners with Microsoft 13
Median Technologies Partners with START 14
MEDIAN Technologies Enters Into Co-Development Agreement With Canon 15
Median Technologies Raises USD21.8 Million in Private Placement of Shares 16
Median Technologies Raises USD22 Million in Private Placement of Shares 17
Median Technologies Raises USD26.5 Million in Private Placement of Units 19
MEDIAN Technologies Completes IPO Of US$14 Million 21
Median Technologies SA, Key Competitors 22
Median Technologies SA, Key Employees 23
Median Technologies SA, Subsidiaries 24

★海外企業調査レポート[Median Technologies SA (ALMDT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Assicurazioni Generali SpA:企業の戦略・SWOT・財務情報
    Assicurazioni Generali SpA - Strategy, SWOT and Corporate Finance Report Summary Assicurazioni Generali SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bellatrix Exploration Ltd (BXE):石油・ガス:M&Aディール及び事業提携情報
    Summary Bellatrix Exploration Ltd (Bellatrix Exploration), formerly True Energy Inc, is an oil and gas that explores and produces light oil and liquids-rich natural gas in the Western Canada Sedimentary Basin. The company develops the Cardium and the Falher or Notikewin intervals in the Western Cana …
  • Sungrow Power Supply Co Ltd (300274):企業の財務・戦略的SWOT分析
    Summary Sungrow Power Supply Co Ltd (Sungrow) is a renewable energy company that manufactures power supply equipment for solar PV (photovoltaic) and wind power projects. The company's products include PV inverters, floating systems, storage systems and accessories. It offers services such as constru …
  • Faurecia S.A.:企業の戦略・SWOT・財務分析
    Faurecia S.A. - Strategy, SWOT and Corporate Finance Report Summary Faurecia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Republic Services Inc (RSG):企業の財務・戦略的SWOT分析
    Republic Services Inc (RSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Canadian Cancer Trials Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Canadian Cancer Trials Group (CCTG), is a subsidiary of Cancer Research Institute at Queen's University, is a contract research organization that conducts clinical trials. The company conducts trials for the development of new drugs and therapies for the treatment of various diseases. It pro …
  • Sunstar Holding AG:企業の戦略・SWOT・財務情報
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Globin Solutions Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globin Solutions Inc (Globin) is a pre-clinical stage biotechnology company with focus on the research and development of antidotal medicines for human poisoning. Its lead compound, Ngb H64Q, an antidote, a mutant version of the protein neuroglobin, has been found to scavenge carbon monoxide …
  • Premier Marketing Public Company Limited:企業の戦略・SWOT・財務情報
    Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Premier Marketing Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Hester Biosciences Ltd (HESTERBIO):企業の財務・戦略的SWOT分析
    Hester Biosciences Ltd (HESTERBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Tennant Co (TNC):企業の財務・戦略的SWOT分析
    Tennant Co (TNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Yokogawa Electric Corporation (6841):企業の財務・戦略的SWOT分析
    Yokogawa Electric Corporation (6841) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • PanOptica Inc-製薬・医療分野:企業M&A・提携分析
    Summary PanOptica Inc (PanOptica) is a biopharmaceutical company that develops new ocular therapies in the field of ophthalmology. The company concentrates on candidates that are at or near the investigational new drug application stage. It licenses and develops novel therapeutics that can improve e …
  • Britannia Industries Ltd (BRITANNIA):企業の財務・戦略的SWOT分析
    Britannia Industries Ltd (BRITANNIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • HSH Nordbank Private Banking:企業の戦略・SWOT・財務情報
    HSH Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary HSH Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • VION N.V.:企業のM&A・事業提携・投資動向
    VION N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VION N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Imvescor Restaurant Group Inc:戦略・SWOT・企業財務分析
    Imvescor Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report Summary Imvescor Restaurant Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Romark Laboratories LC:製薬・医療:M&Aディール及び事業提携情報
    Summary Romark Laboratories LC (Romark Laboratories) is a pharmaceutical company that discovers, develops and commercializes small molecules for the treatment of infectious diseases and cancers. The company develops Nitazoxanide, an oral suspension and tablets used for the treatment of intestinal pa …
  • Immunogen, Inc.:企業の戦略・SWOT・財務分析
    Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Morgans Hotel Group Co:戦略・SWOT・企業財務分析
    Morgans Hotel Group Co - Strategy, SWOT and Corporate Finance Report Summary Morgans Hotel Group Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆